Medrol (methylprednisolone)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Methylprednisolone is a synthetic glucocorticoid.
Methylprednisolone and its derivatives are used principally as anti-inflammatory or immunosuppressant agents. Because methylprednisolone has only minimal mineralocorticoid properties, the drug is inadequate alone for the management of adrenocortical insufficiency. If methylprednisolone is used in the treatment of this condition, concomitant therapy with a mineralocorticoid also is required.
Generic name: methylprednisolone
Pronunciation: (METH-il-pred-NIS-oh-lone)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Medrol
Indications
The following indications are listed for Medrol:
- Acquired Thrombocytopenia
- Acute Exacerbation Of Multiple Sclerosis
- Acute Gouty Arthritis
- Acute Lymphoid Leukemia
- Acute Rheumatic Carditis
- Adrenocortical Insufficiency
- Adrenogenital Disorder
- Allergic Rhinitis
- Angioedema
- Ankylosing Spondylitis
- Aspiration Pneumonitis
- Atopic Dermatitis
- Autoimmune Hemolytic Anemia
- Berylliosis
- Bursitis
- Congenital Adrenal Hyperplasia
- Contact Dermatitis
- Crohn's Disease
- Dermatitis Herpetiformis
- Diagnostic Test For Cushing's Syndrome
- Diamond Blackfan Anemia
- Disseminated Tuberculosis
- Epicondylitis
- Erythema Multiforme
- Erythroblastic Anemia
- Exfoliative Dermatitis
- Follicular Lymphoma
- Hodgkin's Lymphoma
- Humoral Hypercalcemia Of Malignancy
- Hypersensitivity Drug Reaction
- Idiopathic Thrombocytopenic Purpura
- Inflammatory Bowel Disease
- Juvenile Idiopathic Arthritis
- Loffler Syndrome
- Mycosis Fungoides
- Nephrotic Syndrome
- Non-Hodgkin's Lymphoma
- Ocular Inflammation
- Organ Transplant Rejection
- Pemphigus
- Post Traumatic Osteoarthritis
- Primary Adrenocortical Insufficiency
- Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Sarcoidosis
- Serum Sickness
- Severe Persistent Asthma
- Synovitis
- Synovitis Due To Osteoarthritis
- Systemic Dermatomyositis
- Systemic Lupus Erythematosus
- Tendonitis
- Tenosynovitis
- Thyroiditis
- Trichinosis
Also known as: Aase Syndrome, Acquired Hemolytic Anemia Due To Antibodies, Acute Articular Gout, Acute Exacerbation Of Ms, Acute Gout Attack, Acute Gout Flare, Acute Lymphatic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphogenous Leukemia, Acute Relapse Of Ms, Acute Relapse Of Multiple Sclerosis, Acute Uratic Arthritis, Addison Melanoderma, Adrenal Cortical Hypofunction, Adrenal Failure, Adrenal Insufficiency, Adrenocortical Hypofunction, Adrenogenital Syndrome, Anemia Lymphatica, Angioneurotic Edema, Arthritis Deformans, Arthrosis Deformans, Asthenia Pigmentosa, Atopic Eczema, Atrophedema, Axial Spondyloarthritis With Radiographic Sacroiliitis, Bannister's Disease, Bekhterev's Arthritis, Bekhterev's Disease, Bekhterev's Spondylitis, Besnier-Boeck-Schaumann Disease, Besnier-Boeck-Schaumann Syndrome, Blackfan Diamond Syndrome, Blistering Skin Disease, Boeck's Disease, Boeck's Sarcoid, Bullous Dermatitis Herpetiformis, Chronic Adrenocortical Insufficiency, Congenital Erythroid Hypoplastic Anemia, Congenital Hypoplastic Anemia, Congenital Pure Red Cell Aplasia, Congenital Suprarenal Hyperplasia, Constitutional Erythroid Hypoplasia, Deficiency In Bone Marrow Erythroblasts, Dermatitis Venenata, Diagnostic Procedure For Cushing's Syndrome, Disseminated Lupus Erythematosus, Disseminated Neurodermatitis, Drug Hypersensitivity Reaction, Drug-Induced Hypersensitivity, Drug-Induced Hypersensitivity Reaction, Erythema Exfoliativa, Erythema Polymorphe, Erythroblastopenia, Erythroderma Exfoliativa, Erythrogenesis Imperfecta, Exfoliative Eczema, Exfoliative Erythroderma, Follicular B-Cell Lymphoma, Follicular B-Cell Non-Hodgkin's Lymphoma, Giant Urticaria, Hebra's Disease, Herpes Iris, Hodgkin's Disease, Hypercalcemia Associated With Cancer, Hypercalcemia Associated With Malignancy, Hypercalcemia Of Malignancy, Hypoadrenalism, Hypocorticoidism, Immune Thrombocytopenia, Immune Thrombocytopenia Purpura, Inflammation Of The Synovial Membrane, Inflammation Of The Synovium, Juvenile Ra, Juvenile Rheumatoid Arthritis, Loeffler Syndrome, Loffler's Syndrome, Lupus Erythematosus Syndrome, Lymphoblastic Leukemia, Malignant Hypercalcemia, Marie-Strumpell Disease, Marie-Strumpell Spondylitis, Melasma Addisonii, Mendelson's Syndrome, Miliary Tuberculosis, Milton's Disease, Multiple Sclerosis Exacerbation, Nodose Rheumatism, Non-Hodgkin's Type Lymphoma, Ophthalmic Inflammation, Organ Transplant Rejection Reaction, Periodic Urticaria, Pie Syndrome, Post Infectious Thrombocytopenia, Post Traumatic Oa, Post-Traumatic Osteoarthritis, Posttraumatic Osteoarthritis, Primary Adrenal Deficiency, Primary Adrenal Insufficiency, Primary Corticoadrenal Insufficiency, Primary Failure Adrenocortical Insufficiency, Psoriasis Arthropica, Psoriatic Arthropathy, Purpura Hemorrhagica, Quincke's Disease, Quincke's Edema, Regional Enteritis, Regional Ileocolitis, Rheumatic Arthritis, Rheumatic Gout, Rheumatoid Spondylitis, Rhizomelic Spondylitis, Rhizomelic Spondylosis, Schaumann's Syndrome, Secondary Thrombocytopenia, Serum Sickness-Like Reaction, Simple Pulmonary Eosinophilia, Spondylosis Deformans, Strumpell-Marie Disease, Suprarenal Failure, Synovitis Due To Oa, Synovitis With Osteoarthritis, Tendinitis, Tendinous Synovitis, Tendosynovitis, Tendovaginitis, Tenontolemmitis, Tenontothecitis, Tenovaginitis, Transplant Rejection, Trichinella Spiralis Infection, Trichinellosis, Trichiniasis, Urticaria Tuberosa, Werlhof's Disease.
Dosing
No dosing information is available for this tab.
The route of administration and dosage of methylprednisolone and its derivatives depend on the condition being treated and the response of the patient. IM or IV therapy is generally reserved for patients who are unable to take the drug orally or for use in emergency situations. After the initial emergency period, a longer-acting injectable corticosteroid preparation or oral administration of a corticosteroid should be considered.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.